ibrutinib
janssen,abbvie
['lymsm', 'mantle,(-dismantle)', 'ibru', 'lymphoma']
ibrutinib added to standard therapy prolongs progression-free survival in older patients with mantle cell lymphoma #lymsm #hematology #asco22 
News and views from the world of clinical oncology and hematology